Literature DB >> 19184080

Tear fluid concentration of mmp-8 is elevated in non-allergic eosinophilic conjunctivitis and correlates with conjunctival inflammatory cell infiltration.

Osmo Kari1, Marko Määttä, Taina Tervahartiala, Sirje Peltonen, Marjatta Kari, Jaana Hagström, Timo Sorsa, Matti Saari, Tari Haahtela.   

Abstract

BACKGROUND: To investigate tear fluid concentration of matrix metalloproteinase 8 (MMP-8) and its relation to conjunctival inflammatory cell infiltration in persistent non-allergic eosinophilic conjunctivitis (NAEC).
METHODS: Two groups were included: 26 consecutive adult patients with NAEC (conjunctival eosinophils at least 1+ [1-10 eosinophils/slide], skin prick test [SPT] to common allergens negative), and 26 asymptomatic adult persons (no conjunctival eosinophils, SPT negative). MMP-8 tear fluid concentrations were determined by immunofluorometric assay, and conjunctival brush cytology samples from NAEC patients were used for MMP-8 immunocytochemistry. Gelatin zymography was used to illustrate proteolytic activity within the tear fluid samples.
RESULTS: The mean MMP-8 concentration was significantly higher among NAEC patients (214.3 +/- 327.7 microg/l) than among healthy persons (50.4 +/- 62.3 microg/l, P < 0.0001). In the NAEC patients, tear fluid MMP-8 correlated with the numbers of conjunctival neutrophils (r = 0.66, P = 0.0002) as well as with goblet cells and columnar epithelial cells (r = 0.54 for both, P = 0.045), but not with the lymphocyte numbers (r = -0.36, P = 0.0741). By immunocytology, MMP-8 protein could also be detected in vivo in the inflammatory cell population within the conjunctiva. Zymography revealed that proteolysis was significantly higher in the NAEC group, and activated enzymes were practically found only in the NAEC group.
CONCLUSIONS: The results showed that NAEC is an inflammatory condition characterized by increased tear fluid MMP-8 levels, probably derived from both inflammatory and structural conjunctival cells. The increased proteolytic activity in NAEC patients may indicate risk of conjunctival structural changes (remodeling).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184080     DOI: 10.1007/s00417-009-1042-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  26 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium.

Authors:  Rosa M Corrales; Michael E Stern; Cintia S De Paiva; Jonathan Welch; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.

Authors:  Marko Määttä; Taina Tervahartiala; Eija Vesti; Juhani Airaksinen; Timo Sorsa
Journal:  J Glaucoma       Date:  2006-06       Impact factor: 2.503

Review 4.  Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics.

Authors:  Christopher M Overall; G Angus McQuibban; Ian Clark-Lewis
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

5.  Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.

Authors:  Hannele M Virtanen; Sakari Reitamo; Marjatta Kari; Osmo Kari
Journal:  Acta Ophthalmol Scand       Date:  2006-10

6.  A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies.

Authors:  H Matsuki; N Fujimoto; K Iwata; V Knäuper; Y Okada; T Hayakawa
Journal:  Clin Chim Acta       Date:  1996-01-31       Impact factor: 3.786

7.  Group IIA phospholipase A(2) concentration of tears in patients with ocular rosacea.

Authors:  Osmo Kari; Valtteri V Aho; Sirje Peltonen; Jukka M Saari; Marjatta Kari; Marko Määttä; Yrjö Collan; K Matti Saari
Journal:  Acta Ophthalmol Scand       Date:  2005-08

8.  Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases.

Authors:  T Sorsa; Y Ding; T Salo; A Lauhio; O Teronen; T Ingman; H Ohtani; N Andoh; S Takeha; Y T Konttinen
Journal:  Ann N Y Acad Sci       Date:  1994-09-06       Impact factor: 5.691

Review 9.  Matrix metalloproteinases in immunity.

Authors:  E J Goetzl; M J Banda; D Leppert
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

10.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Authors:  U Schönbeck; F Mach; P Libby
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

View more
  4 in total

1.  Association between allergic conjunctivitis and provisional tic disorder in children.

Authors:  Lin Chen; Xinke Chen; Ning Ke; Lianhong Pi; Qing Liu
Journal:  Int Ophthalmol       Date:  2019-09-29       Impact factor: 2.031

2.  Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.

Authors:  Samer N Arafat; Ana M Suelves; Sandra Spurr-Michaud; James Chodosh; C Stephen Foster; Claes H Dohlman; Ilene K Gipson
Journal:  Ophthalmology       Date:  2013-08-17       Impact factor: 12.079

3.  Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice.

Authors:  Nancy J Reyes; Chen Yu; Rose Mathew; Carolina M Kunnen; Joan Kalnitsky; Rachel L Redfern; Andrea Leonardi; Victor L Perez; Amanda S MacLeod; Preeya K Gupta; Daniel R Saban
Journal:  Sci Transl Med       Date:  2018-07-25       Impact factor: 17.956

4.  Dry Eye Syndrome and Allergic Conjunctivitis in the Pediatric Population.

Authors:  Handan Akil; Fatih Celik; Fatih Ulas; Ilknur Surucu Kara
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.